Signup Crypto ETF Stocks News

FINANCIAL 15 SPLIT CORP. Monthly Dividend Declaration for Class A & Preferred Share

TORONTO, June 18, 2025 ( GLOBE NEWSWIRE ) -- Financial 15 Split Corp. ( "Financial 15" ) declares its regular monthly distribution of $0.12570 for each Class A share ( $1.51 annualized ) and $0.07083 for each Preferred share ( $0.850 annually ) .

Source: www.globenewswire.com
June 18, 2025 | 13:00:00
Category: News

M Split Corp. Monthly Dividend Declared for Class I Preferred Shares

TORONTO, June 18, 2025 ( GLOBE NEWSWIRE ) -- M Split Corp. ( "M Split" ) declares its monthly distribution of $0.03125 per share ( $0.375 annually ) for Class I Preferred shareholders. The Class I Preferred share dividends are paid at an annual rate of 7.50% based on the $5 notional issue price.

Source: www.globenewswire.com
June 18, 2025 | 13:00:00
Category: News

IZEA Announces Final Results of its Modified Dutch Auction Tender Offer

ORLANDO, Fla., June 18, 2025 ( GLOBE NEWSWIRE ) -- IZEA Worldwide, Inc. ( NASDAQ: IZEA ) , a leading influencer marketing company that makes Creator Economy solutions for marketers, announced today the preliminary results of its modified "Dutch auction" tender offer ( the "Offer" ) to repurchase ...

Source: www.globenewswire.com
June 18, 2025 | 13:00:00
Category: News

Commerce Split Monthly Payments Declared for Capital Share and Preferred Shares

TORONTO, June 18, 2025 ( GLOBE NEWSWIRE ) -- New Commerce Split ( The "Company" ) declares a monthly distribution of $0.05000 per share for Capital shareholders ( YCM ) , and its regular monthly distribution of $0.02500 per share ( $0.30 annually ) for Class I Preferred shareholders ( YCM.PR.A ) ...

Source: www.globenewswire.com
June 18, 2025 | 13:00:00
Category: News

North American Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share

TORONTO, June 18, 2025 ( GLOBE NEWSWIRE ) -- North American Financial 15 Split Corp. ( The "Company" ) declares its regular monthly distribution of $0.11335 for each Class A share ( $1.3602 annualized ) and $0.07292 for each Preferred share ( $0.875 annually ) .

Source: www.globenewswire.com
June 18, 2025 | 13:00:00
Category: News

Prime Dividend Corp. Monthly Dividend Declaration for Class A & Preferred Share

TORONTO, June 18, 2025 ( GLOBE NEWSWIRE ) -- Prime Dividend Corp. ( The "Company" ) declares its monthly distribution of $0.07092 for each Class A share and $0.06083 for each Preferred share. Distributions are payable July 10, 2025 to shareholders on record as at June 30, 2025.

Source: www.globenewswire.com
June 18, 2025 | 13:00:00
Category: News

SunRocket Capital Provides Financing for Golden Gate Capital's C&I Rooftop Solar Installation in New Jersey

MIAMI, June 18, 2025 ( GLOBE NEWSWIRE ) -- SunRocket Capital, a structured finance partner to solar developers, is pleased to announce the closing of financing with Golden Gate Capital for a rooftop solar installation project in Cherry Hill, New Jersey.

Source: www.benzinga.com
June 18, 2025 | 11:02:00
Category: News

Prediction: XRP Will Be Worth This Much in 5 Years

Within five years, XRP ( CRYPTO: XRP ) could be a $750 billion digital asset. On the surface, that might sound like an impossibly high, pie-in-the-sky prediction. It would require XRP to quintuple in price, from a little more than $2 to $10, within a relatively short period of time.However, a ...

Source: www.fool.com
June 18, 2025 | 11:10:00
Category: News

3 High-Yield Dividend Stocks to Buy for the Second Half of 2025

If you've been investing for a while, chances are you've read about maintaining a balanced portfolio. But sometimes it's hard to know the benefits of diversification unless you've experienced them first-hand.Earlier this year, many growth stocks tanked while value stocks, from Berkshire Hathaway ...

Source: www.fool.com
June 18, 2025 | 11:15:00
Category: News

F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim

MANCHESTER, United Kingdom, June 18, 2025 ( GLOBE NEWSWIRE ) -- F2G Ltd, a clinical-stage biopharmaceutical company developing olorofim, a novel therapy to treat life-threatening rare fungal infections with high unmet medical need, today announced the publication of the full data set from its ...

Source: www.benzinga.com
June 18, 2025 | 11:20:14
Category: General

© Natavest 2025 - 2026